A Study of XmAb23104 in People With Sarcoma

Summary

The purpose of this study is to find out whether the study drug, XmAb23104, is an effective treatment for advanced sarcoma. The researchers will also look at whether XmAb23104 is safe and causes few or mild side effects in participants.

Timeline

Start

2023-04-06

Primary completion

2024-07-19

Completion

2024-07-19

Outcome

Outcome not reported

Stopped: “Vendor decided study to be closed early”

Drugs

Indications